How should I manage a 17-year-old female with recurrent dysuria, initial urinalysis positive for leukocyte esterase (LE) and nitrites, previously treated with nitrofurantoin, now with repeat positive urinalysis and initial urine culture showing Staphylococcus saprophyticus (no susceptibility testing) and PCR positive for Ureaplasma parvum?

Management of Recurrent UTI with S. saprophyticus and U. parvum

Treat the recurrent symptoms with a 7-day course of an alternative antibiotic (not nitrofurantoin), specifically trimethoprim-sulfamethoxazole or a cephalosporin, targeting the S. saprophyticus; the Ureaplasma parvum finding is likely clinically irrelevant and should not be treated.

Rationale for Treatment Approach

Why Retreatment is Necessary

Your patient has recurrent symptoms with positive urinalysis shortly after completing nitrofurantoin therapy. According to the 2024 EAU guidelines, when symptoms recur within 2-4 weeks after treatment completion, you should assume the organism is not susceptible to the original antibiotic and retreat with a different agent for 7 days 1. This represents either treatment failure or rapid reinfection with a resistant organism.

Addressing the S. saprophyticus

S. saprophyticus is the second most common cause of uncomplicated cystitis in young women and is typically susceptible to standard UTI antibiotics 2. Recent data shows that S. saprophyticus maintains excellent susceptibility to nitrofurantoin (100%), trimethoprim-sulfamethoxazole (95%), and ciprofloxacin (100%) 3. However, since nitrofurantoin already failed clinically in your patient:

Recommended alternatives:

• Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days 1
• Cephalosporin (e.g., cefadroxil 500 mg twice daily) for 7 days if local E. coli resistance is <20% 1

The 7-day duration is critical here rather than the standard 3-5 day course for initial cystitis, as this represents treatment failure 1.

The Ureaplasma parvum Dilemma

Do not treat the Ureaplasma parvum. Here's why:

• Ureaplasma species are common urogenital commensals found in 40-80% of sexually active women without causing disease
• There is no established role for Ureaplasma in causing typical UTI symptoms (dysuria, frequency, urgency)
• The positive PCR likely represents colonization, not infection
• Your patient's symptoms and positive LE/nitrites are fully explained by the S. saprophyticus

Important caveat: Ureaplasma may be relevant in specific contexts (pregnancy complications, neonatal infections, urethritis in men), but not in straightforward recurrent cystitis in a young woman [@general medical knowledge@].

Diagnostic Considerations

The initial culture showing S. saprophyticus without sensitivities is problematic. Request susceptibility testing on the current specimen if you obtain a new culture, though the 2024 EAU guidelines note that culture isn't mandatory for typical recurrent cystitis if symptoms are classic 1. However, given the treatment failure, culture with sensitivities would be prudent to guide therapy.

Common Pitfalls to Avoid

1. Don't treat asymptomatic bacteriuria or positive dipsticks without symptoms - The positive LE and nitrites only matter in the context of symptoms 4, 5

2. Don't assume nitrofurantoin resistance is common - S. saprophyticus typically remains susceptible 3, so this likely represents inadequate duration, poor compliance, or rapid reinfection rather than true resistance

3. Don't chase the Ureaplasma - This will lead to unnecessary antibiotic exposure (typically requiring doxycycline or azithromycin) without addressing the actual problem

4. Don't use fluoroquinolones as first-line - Reserve these for complicated infections or when other options have failed, given resistance concerns and adverse effect profiles 1, 6

Prevention Strategy

After treating the acute episode, address recurrence prevention since this patient now has 2 UTIs in a short timeframe:

• Behavioral counseling: Increase fluid intake, post-coital voiding if sexually active 1
• Consider prophylaxis if she develops ≥3 UTIs in 12 months or 2 in 6 months 1:
  • Continuous low-dose prophylaxis (nitrofurantoin 50-100 mg daily, or TMP-SMX single strength 3x/week)
  • Post-coital prophylaxis if UTIs are temporally related to intercourse
  • Self-start therapy with patient education 1

Monitoring

• Symptoms should improve within 48-72 hours of appropriate therapy
• No routine post-treatment culture is needed if symptoms resolve 1
• If symptoms persist or recur again, then obtain culture with full sensitivities and consider urologic evaluation for anatomic abnormalities (though not routinely needed in women <40 without risk factors) 1